The decisions made at the Greater Manchester Medicines Management Group (GMMMG) January 2025 and April 2025 meetings have now been reviewed by GM Executive and can be found at https://gmmmg.nhs.uk/meetings/decision-summaries/.
Updates to formulary and RAG list
- Tirzepatide – red, for use in specialist weight management services. Proposals for use in other settings are in development and will be added to formulary in due course.
- Modafinil for MS-relate fatigue – green (specialist initiation)
- Alverine citrate with simeticone – green, third line choice
- Vibegron for overactive bladder – green, alternative choice
- Drospirenone 4mg for oral contraception – green, third line choice
Available at https://www.greatermanchesterformulary.nhs.uk/. Links to NICE guidance and MHRA safety advice added as appropriate. For full details of formulary and RAG updates, see the decision summaries available at https://gmmmg.nhs.uk/meetings/decision-summaries/.
Colleagues are asked disseminate for implementation within your organisations.
All approved CRG and GMMMG meeting minutes can be found at: https://gmmmg.nhs.uk/meetings/clinical-reference-group/ and https://gmmmg.nhs.uk/meetings/gmmmg-meetings/.